Javascript doit fonctionner ! Activez-le et rechargez cette page.
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:carboplatin-etoposide-vincristine regimen'
(id=6896411 ; fe=en:carboplatin-etoposide-vincristine regimen ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=995 creation date=2017-06-25 touchdate=2025-05-13 07:30:05.000)
≈ 33 relations sortantes

  1. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 42 / 1 -> en:chemotherapy regimen used to treat endometrial carcinoma
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat endometrial carcinoma | rel=r_associated | relid=0 | w=42
  2. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 39 / 0.929 -> en:chemotherapy regimen used to treat gestational trophoblastic tumor
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat gestational trophoblastic tumor | rel=r_associated | relid=0 | w=39
  3. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 39 / 0.929 -> en:etoposide
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:etoposide | rel=r_associated | relid=0 | w=39
  4. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 37 / 0.881 -> en:chemotherapy regimen used to treat hodgkins lymphoma
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat hodgkins lymphoma | rel=r_associated | relid=0 | w=37
  5. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 36 / 0.857 -> en:chemotherapy regimen used to treat cervical carcinoma
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat cervical carcinoma | rel=r_associated | relid=0 | w=36
  6. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 36 / 0.857 -> en:chemotherapy regimen used to treat malignant brain neoplasm
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat malignant brain neoplasm | rel=r_associated | relid=0 | w=36
  7. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 36 / 0.857 -> en:chemotherapy regimen used to treat non-hodgkin lymphoma
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat non-hodgkin lymphoma | rel=r_associated | relid=0 | w=36
  8. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 36 / 0.857 -> en:chemotherapy regimen used to treat prostate carcinoma
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat prostate carcinoma | rel=r_associated | relid=0 | w=36
  9. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 35 / 0.833 -> en:chemotherapy regimen used to treat bladder carcinoma
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat bladder carcinoma | rel=r_associated | relid=0 | w=35
  10. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 35 / 0.833 -> en:chemotherapy regimen used to treat esophageal carcinoma
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat esophageal carcinoma | rel=r_associated | relid=0 | w=35
  11. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 35 / 0.833 -> en:chemotherapy regimen used to treat melanoma
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat melanoma | rel=r_associated | relid=0 | w=35
  12. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 35 / 0.833 -> en:chemotherapy regimen used to treat sarcoma
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat sarcoma | rel=r_associated | relid=0 | w=35
  13. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 32 / 0.762 -> en:chemotherapy regimen used to treat gastric carcinoma
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat gastric carcinoma | rel=r_associated | relid=0 | w=32
  14. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 32 / 0.762 -> en:chemotherapy regimen used to treat malignant head and neck neoplasm
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat malignant head and neck neoplasm | rel=r_associated | relid=0 | w=32
  15. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 32 / 0.762 -> en:chemotherapy regimen used to treat non-small cell lung carcinoma
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat non-small cell lung carcinoma | rel=r_associated | relid=0 | w=32
  16. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 32 / 0.762 -> en:chemotherapy regimen used to treat plasma cell myeloma
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat plasma cell myeloma | rel=r_associated | relid=0 | w=32
  17. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 32 / 0.762 -> en:chemotherapy regimen used to treat primary malignant neoplasm of liver
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat primary malignant neoplasm of liver | rel=r_associated | relid=0 | w=32
  18. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 32 / 0.762 -> en:chemotherapy regimen used to treat small cell lung carcinoma
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat small cell lung carcinoma | rel=r_associated | relid=0 | w=32
  19. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 32 / 0.762 -> en:cyclophosphamide-etoposide-vincristine regimen
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:cyclophosphamide-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=32
  20. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 31 / 0.738 -> en:chemotherapy regimen used to treat breast carcinoma
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat breast carcinoma | rel=r_associated | relid=0 | w=31
  21. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 31 / 0.738 -> en:chemotherapy regimen used to treat chronic lymphocytic leukemia
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat chronic lymphocytic leukemia | rel=r_associated | relid=0 | w=31
  22. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 31 / 0.738 -> en:chemotherapy regimen used to treat pancreatic carcinoma
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat pancreatic carcinoma | rel=r_associated | relid=0 | w=31
  23. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 30 / 0.714 -> en:busulfan/melphalan regimen
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:busulfan/melphalan regimen | rel=r_associated | relid=0 | w=30
  24. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 30 / 0.714 -> en:chemotherapy regimen used to treat acute myeloid leukemia
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat acute myeloid leukemia | rel=r_associated | relid=0 | w=30
  25. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 30 / 0.714 -> en:chemotherapy regimen used to treat malignant testicular neoplasm
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat malignant testicular neoplasm | rel=r_associated | relid=0 | w=30
  26. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 30 / 0.714 -> en:vincristine
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:vincristine | rel=r_associated | relid=0 | w=30
  27. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 29 / 0.69 -> en:chemotherapy regimen used to treat acute lymphoblastic leukemia
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat acute lymphoblastic leukemia | rel=r_associated | relid=0 | w=29
  28. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 29 / 0.69 -> en:chemotherapy regimen used to treat malignant mesothelioma
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat malignant mesothelioma | rel=r_associated | relid=0 | w=29
  29. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 29 / 0.69 -> en:chemotherapy regimen used to treat malignant renal neoplasm
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat malignant renal neoplasm | rel=r_associated | relid=0 | w=29
  30. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 27 / 0.643 -> en:carboplatin
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:carboplatin | rel=r_associated | relid=0 | w=27
  31. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 27 / 0.643 -> en:chemotherapy regimen used to treat colorectal carcinoma
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat colorectal carcinoma | rel=r_associated | relid=0 | w=27
  32. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 27 / 0.643 -> en:chemotherapy regimen used to treat malignant ovarian neoplasm
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:chemotherapy regimen used to treat malignant ovarian neoplasm | rel=r_associated | relid=0 | w=27
  33. en:carboplatin-etoposide-vincristine regimen -- r_associated #0: 2 / 0.048 -> en:therapeutic or preventive procedure
    n1=en:carboplatin-etoposide-vincristine regimen | n2=en:therapeutic or preventive procedure | rel=r_associated | relid=0 | w=2
≈ 35 relations entrantes

  1. en:chemotherapy regimen used to treat gestational trophoblastic tumor --- r_associated #0: 41 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat gestational trophoblastic tumor | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=41
  2. en:chemotherapy regimen used to treat esophageal carcinoma --- r_associated #0: 35 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat esophageal carcinoma | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=35
  3. en:chemotherapy regimen used to treat prostate carcinoma --- r_associated #0: 35 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat prostate carcinoma | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=35
  4. en:chemotherapy regimen used to treat sarcoma --- r_associated #0: 35 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat sarcoma | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=35
  5. en:busulfan/melphalan regimen --- r_associated #0: 34 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:busulfan/melphalan regimen | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=34
  6. en:chemotherapy regimen used to treat cervical carcinoma --- r_associated #0: 34 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat cervical carcinoma | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=34
  7. en:chemotherapy regimen used to treat chronic lymphocytic leukemia --- r_associated #0: 34 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat chronic lymphocytic leukemia | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=34
  8. en:chemotherapy regimen used to treat malignant ovarian neoplasm --- r_associated #0: 34 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat malignant ovarian neoplasm | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=34
  9. en:chemotherapy regimen used to treat gastric carcinoma --- r_associated #0: 32 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat gastric carcinoma | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=32
  10. en:chemotherapy regimen used to treat melanoma --- r_associated #0: 32 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat melanoma | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=32
  11. en:chemotherapy regimen used to treat endometrial carcinoma --- r_associated #0: 31 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat endometrial carcinoma | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=31
  12. en:chemotherapy regimen used to treat primary malignant neoplasm of liver --- r_associated #0: 31 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat primary malignant neoplasm of liver | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=31
  13. en:chemotherapy regimen used to treat non-hodgkin lymphoma --- r_associated #0: 30 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat non-hodgkin lymphoma | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=30
  14. en:chemotherapy regimen used to treat small cell lung carcinoma --- r_associated #0: 30 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat small cell lung carcinoma | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=30
  15. en:cyclophosphamide-etoposide-vincristine regimen --- r_associated #0: 30 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:cyclophosphamide-etoposide-vincristine regimen | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=30
  16. en:carboplatin --- r_associated #0: 29 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:carboplatin | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=29
  17. en:chemotherapy regimen used to treat breast carcinoma --- r_associated #0: 29 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat breast carcinoma | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=29
  18. en:chemotherapy regimen used to treat colorectal carcinoma --- r_associated #0: 29 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat colorectal carcinoma | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=29
  19. en:chemotherapy regimen used to treat hodgkins lymphoma --- r_associated #0: 29 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat hodgkins lymphoma | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=29
  20. en:chemotherapy regimen used to treat malignant head and neck neoplasm --- r_associated #0: 29 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat malignant head and neck neoplasm | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=29
  21. en:chemotherapy regimen used to treat malignant renal neoplasm --- r_associated #0: 29 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat malignant renal neoplasm | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=29
  22. en:chemotherapy regimen used to treat malignant brain neoplasm --- r_associated #0: 28 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat malignant brain neoplasm | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=28
  23. en:chemotherapy regimen used to treat malignant mesothelioma --- r_associated #0: 28 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat malignant mesothelioma | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=28
  24. en:chemotherapy regimen used to treat malignant testicular neoplasm --- r_associated #0: 28 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat malignant testicular neoplasm | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=28
  25. en:chemotherapy regimen used to treat non-small cell lung carcinoma --- r_associated #0: 28 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat non-small cell lung carcinoma | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=28
  26. en:chemotherapy regimen used to treat acute lymphoblastic leukemia --- r_associated #0: 27 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat acute lymphoblastic leukemia | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=27
  27. en:chemotherapy regimen used to treat acute myeloid leukemia --- r_associated #0: 27 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat acute myeloid leukemia | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=27
  28. en:chemotherapy regimen used to treat plasma cell myeloma --- r_associated #0: 27 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat plasma cell myeloma | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=27
  29. en:chemotherapy regimen used to treat bladder carcinoma --- r_associated #0: 26 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat bladder carcinoma | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=26
  30. en:chemotherapy regimen used to treat pancreatic carcinoma --- r_associated #0: 26 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:chemotherapy regimen used to treat pancreatic carcinoma | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=26
  31. en:vincristine --- r_associated #0: 24 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:vincristine | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=24
  32. en:etoposide --- r_associated #0: 22 --> en:carboplatin-etoposide-vincristine regimen
    n1=en:etoposide | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=22
  33. carboplatine --- r_associated #0: 10 --> en:carboplatin-etoposide-vincristine regimen
    n1=carboplatine | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=10
  34. vincristine --- r_associated #0: 10 --> en:carboplatin-etoposide-vincristine regimen
    n1=vincristine | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=10
  35. étoposide --- r_associated #0: 10 --> en:carboplatin-etoposide-vincristine regimen
    n1=étoposide | n2=en:carboplatin-etoposide-vincristine regimen | rel=r_associated | relid=0 | w=10
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr